Company Filing History:
Years Active: 2013-2019
Title: Syue-Yi Lyu: Innovator in Pharmaceutical Compounds
Introduction
Syue-Yi Lyu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit bacterial growth. With a total of 3 patents to his name, Lyu's work is recognized for its potential impact on medical treatments.
Latest Patents
Lyu's latest patents include innovative compounds and methods aimed at combating bacterial infections. One of his notable inventions is titled "Teicoplanin analogs and uses thereof." This patent describes compounds of Formula (I) and their pharmaceutically acceptable salts, which are useful for inhibiting bacterial growth. The patent also outlines methods for treating and preventing bacterial infections using these compounds.
Another significant patent is "Structural and mechanistic basis for novel compound biosynthesis using 4-electron hexose oxidase." This invention discloses a novel pharmaceutical composition comprising a compound of formula (I), which can include a pharmaceutically acceptable carrier. The patent further details methods for synthesizing these compounds using Dbv29 and their application in treating bacterial infections.
Career Highlights
Syue-Yi Lyu is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to focus on groundbreaking research in pharmaceutical sciences. Lyu's contributions have been instrumental in advancing the understanding of bacterial infections and developing effective treatments.
Collaborations
Lyu has collaborated with notable colleagues, including Tsung-Lin Li and Yu-Chen Liu. These collaborations have fostered a productive research environment, leading to innovative discoveries in the field of pharmaceuticals.
Conclusion
Syue-Yi Lyu is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly impact the treatment of bacterial infections. His innovative patents and collaborations highlight his commitment to advancing medical science.